Search

TransMedics Group Inc

Отворен

СекторЗдравеопазване

86.55 -1.03

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

85.09

Максимум

88.47

Ключови измерители

By Trading Economics

Приходи

7.4M

15M

Продажби

16M

190M

P/E

Средно за сектора

22.244

56.432

EPS

0.44

Марж на печалбата

7.729

Служители

898

EBITDA

-889K

27M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+7.61% upside

Дивиденти

By Acuity

Следващи печалби

28.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

159M

3B

Предишно отваряне

87.58

Предишно затваряне

86.55

Настроения в новините

By Acuity

86%

14%

309 / 339 Класиране в Healthcare

TransMedics Group Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.09.2026 г., 20:10 ч. UTC

Transmedics Group Inc shares fell modestly amid a broader market decline, stabilizing near the midpoint of its one-month range.

15.09.2026 г., 20:07 ч. UTC

Social Media

TransMedics Group shares are rising following an insider purchase by Director David Weill at $81.63, amid positive social media discussions about the company.

14.09.2026 г., 20:03 ч. UTC

TransMedics Group Inc shares are gaining during Monday's session, despite earlier pullbacks. Broader market volatility is influenced by rising crude oil prices and inflation concerns.

11.09.2026 г., 20:02 ч. UTC

News
Event
Social Media

TransMedics Group Inc shares are lower following the announcement of a CFO transition. The company reaffirmed its 2026 revenue guidance of $737 million to $757 million.

10.09.2026 г., 20:06 ч. UTC

Transmedics Group Inc shares are lower amid broader market pressure, reflecting ongoing concerns over rising Treasury yields and inflation. No specific company news was identified.

9.09.2026 г., 20:07 ч. UTC

Social Media

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

8.09.2026 г., 19:56 ч. UTC

News
Social Media

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

4.09.2026 г., 20:07 ч. UTC

News

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2.09.2026 г., 19:56 ч. UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

1.09.2026 г., 20:09 ч. UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.

31.08.2026 г., 20:03 ч. UTC

Transmedics Group Inc shares are declining amid broader economic concerns following remarks from Warsh at the Jackson Hole Economic Symposium.

28.08.2026 г., 20:07 ч. UTC

Transmedics Group Inc shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and no specific company news identified.

27.08.2026 г., 19:16 ч. UTC

Transmedics Group Inc. shares are lower amid broader market concerns about persistent U.S. inflation, despite a brief midday rebound earlier in the session.

26.08.2026 г., 21:36 ч. UTC

Transmedics Group Inc. shares declined slightly in after-market trading, reflecting broader market caution ahead of Nvidia's earnings report and recent inflation data.

25.08.2026 г., 19:46 ч. UTC

TransMedics Group Inc is trading lower today, with no specific news identified. The stock remains near its one-month range's upper end.

24.08.2026 г., 23:06 ч. UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

21.08.2026 г., 19:36 ч. UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

20.08.2026 г., 19:46 ч. UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

19.08.2026 г., 23:11 ч. UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

18.08.2026 г., 19:16 ч. UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

13.08.2026 г., 19:52 ч. UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

12.08.2026 г., 19:36 ч. UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

11.08.2026 г., 19:16 ч. UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

10.08.2026 г., 19:21 ч. UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

7.08.2026 г., 19:22 ч. UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

6.08.2026 г., 20:03 ч. UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

5.08.2026 г., 20:03 ч. UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

4.08.2026 г., 23:02 ч. UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

3.08.2026 г., 19:51 ч. UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

30.07.2026 г., 19:03 ч. UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

Сравнение с други в отрасъла

Ценова промяна

TransMedics Group Inc Прогноза

Ценова цел

By TipRanks

7.61% нагоре

12-месечна прогноза

Среден 94.222 USD  7.61%

Висок 122 USD

Нисък 65 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за TransMedics Group Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

7

Купи

4

Задържане

0

Продай

Настроение

By Acuity

309 / 339 Класиране в Здравеопазване

Настроения в новините

Много силни мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat